These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 8708020)

  • 21. Topical immunotherapy of alopecia areata.
    van der Steen PH; Happle R
    Dermatol Clin; 1993 Jul; 11(3):619-22. PubMed ID: 8365044
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Topical immunotherapy in dermatology.
    Buckley DA; du Vivier AW
    Int J Clin Pract; 1999 Mar; 53(2):130-7. PubMed ID: 10344049
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Contact allergy as a therapeutic tool for alopecia areata: application of squaric acid dibutylester.
    Happle R; Kalveram KJ; Büchner U; Echternacht-Happle K; Göggelmann W; Summer KH
    Dermatologica; 1980; 161(5):289-97. PubMed ID: 7439477
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Topical immunotherapy in combination with anthralin in the treatment of refractory alopecia areata.
    Kagami S; Kishi Y; Hino H
    J Cosmet Dermatol; 2020 Sep; 19(9):2411-2414. PubMed ID: 32621407
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alopecia areata: more on topical sensitizers.
    Orecchia G; Marelli MA; Perfetti L; Rabbiosi G
    Dermatologica; 1990; 180(2):57-9. PubMed ID: 2311796
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The pattern and profile of alopecia areata in Singapore--a study of 219 Asians.
    Tan E; Tay YK; Goh CL; Chin Giam Y
    Int J Dermatol; 2002 Nov; 41(11):748-53. PubMed ID: 12452996
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of alopecia areata with nonablative fractional laser combined with topical minoxidil.
    Wang W; Gegentana ; Tonglaga ; Bagenna ; Li Y
    J Cosmet Dermatol; 2019 Aug; 18(4):1009-1013. PubMed ID: 31245963
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of alopecia areata with topical sensitizers.
    Sutherland L; Laschinger M; Syed ZU; Gaspari A
    Dermatitis; 2015; 26(1):26-31. PubMed ID: 25581667
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Sensitization therapy in severe alopecia areata].
    Tosti A; Guerra L; Capobianco C; Brasile GP
    G Ital Dermatol Venereol; 1988 Nov; 123(11):571-3. PubMed ID: 3254331
    [No Abstract]   [Full Text] [Related]  

  • 30. Topical immunotherapy with contact allergens in alopecia areata: evidence for non-specific systemic suppression of cellular immune reactions.
    Bröcker EB; John SM; Steinhausen D; Hamm H
    Arch Dermatol Res; 1991; 283(2):133-4. PubMed ID: 2069412
    [No Abstract]   [Full Text] [Related]  

  • 31. Alopecia areata in children: treatment with diphencyprone.
    Schuttelaar ML; Hamstra JJ; Plinck EP; Peereboom-Wynia JD; Vuzevski VD; Mulder PG; Oranje AP
    Br J Dermatol; 1996 Oct; 135(4):581-5. PubMed ID: 8915150
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Systemic steroids with or without 2% topical minoxidil in the treatment of alopecia areata.
    Olsen EA; Carson SC; Turney EA
    Arch Dermatol; 1992 Nov; 128(11):1467-73. PubMed ID: 1444500
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic factors for clinical response of alopecia areata to topical immunotherapy with squaric acid dibutylester.
    Iijima S; Otsuka F
    Arch Dermatol; 1997 Apr; 133(4):539-40. PubMed ID: 9126022
    [No Abstract]   [Full Text] [Related]  

  • 34. Topical 2% tofacitinib for children with alopecia areata, alopecia totalis, and alopecia universalis.
    Putterman E; Castelo-Soccio L
    J Am Acad Dermatol; 2018 Jun; 78(6):1207-1209.e1. PubMed ID: 29754888
    [No Abstract]   [Full Text] [Related]  

  • 35. [Pigmentation abnormalities in the course of topical immunotherapy of alopecia areata].
    Valsecchi R; Pansera B; Rossi A; Cainelli T
    G Ital Dermatol Venereol; 1989; 124(1-2):31-2. PubMed ID: 2527809
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pulsed administration of corticosteroids in the treatment of alopecia areata.
    Sharma VK
    Int J Dermatol; 1996 Feb; 35(2):133-6. PubMed ID: 8850047
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of pediatric alopecia areata with anthralin: A retrospective study of 37 patients.
    Wu SZ; Wang S; Ratnaparkhi R; Bergfeld WF
    Pediatr Dermatol; 2018 Nov; 35(6):817-820. PubMed ID: 30338548
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and safety of the topical sensitizer squaric acid dibutyl ester in Alopecia areata and factors influencing the outcome.
    Ajith C; Gupta S; Kanwar AJ
    J Drugs Dermatol; 2006 Mar; 5(3):262-6. PubMed ID: 16573260
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [In situ lymphocyte subpopulation in alopecia areata after treatment with squaric acid dibutyl ester].
    Rosso R; Paulli M; Marelli MA; Douville H; Orecchia G
    G Ital Dermatol Venereol; 1988 Nov; 123(11):575-7. PubMed ID: 3254332
    [No Abstract]   [Full Text] [Related]  

  • 40. Therapeutic approach with squaric acid dibutylester for steroid resistant-alopecia areata incognita: A pilot study of a single center.
    Starace M; Vezzoni R; Alessandrini A; Bruni F; Carpanese MA; Misciali C; Sechi A; Piraccini BM
    Dermatol Ther; 2021 Sep; 34(5):e15096. PubMed ID: 34390608
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.